HA
Hansa Biopharma
SEMid Cap
Latest price
38.24 SEK
17/09/2026
Latest (1)
150.00 SEK
+292.26%
Upside
AVG (0)
–
Upside
HNSA
3 mo
6 mo+16.37%2 price targets
1 yr+148.43%7 price targets
Max 7 price targets
HealthcareBiotechnology
Overview
Analysts
About The Company
Hansa Biopharma AB is a Swedish biopharmaceutical company developing immunomodulatory enzyme treatments for rare immunological conditions. The company focuses on developing treatments for organ transplantation and autoimmune diseases.
Wikipedia
Latest Target
The most recently set price target for the stock, from a single analyst.
Target
150.00 SEK
Upside
+292.26%
Latest price38.24 SEK
Consensus
Consensus
95.00 SEK
Upside
+148.43%
Based on older targets - no fresh targets in the last 90 days.
Latest price38.24 SEK
Insider Trades for Hansa Biopharma
No insider trades for the selected period.